Back to company

BIOMOTION PHARMA ApS: Financial statements 2016

CVR: 12928203

BIOMOTION PHARMA ApS (CVR 12928203) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -1,982 the year before. Equity amounted to DKK -999.

Gross Profit
0 kr.
Profit/Loss
0 kr.
Equity
-999 kr.
Total Assets
251 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-00-999-
2015-3 t.-2 t.-999-
2014--999-999983-
2013-3 t.3 t.2 t.-
2012-3 t.3 t.-1 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOMOTION PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

BIOMOTION PHARMA ApS: The 2015 annual report is outFeb 29, 2016

BIOMOTION PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 3,018, and the net result was DKK -1,982.

About BIOMOTION PHARMA ApS

BIOMOTION PHARMA ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1989. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANDEL OG INVESTERING AF 1989 ApS and DANSK FARMASAN A/S. The management consists of Henrik Selchau Poulsen. The company is owned by Michael Rasmussen. In 2024, the company reported a gross profit of DKK -5,313 and a net result of DKK -6,460 compared with DKK -1,430 the year before. Equity amounted to DKK 3,310.